In the current study, we aimed to evaluate the procedural safety, clinical, and angiographic outcome of CAS for severe (≥70%) RIS using atherosclerotic stenosis (AS) as a control.
xternal radiation for head-and-neck cancers may cause extracranial carotid stenosis. [1] [2] [3] [4] Endarterectomy may reduce the absolute risk of ipsilateral stroke by 17% in 2 years for patients with symptomatic carotid stenosis ≥70%. 5, 6 However, endarterectomy could be difficult in radiation-induced carotid stenosis (RIS) because of arterial wall fibrosis, tissue plane scarring, prosthetic infection, anastomotic dehiscence, surgically inaccessible proximal lesions, and an increased risk of wound complications and restenosis. [7] [8] [9] [10] Moreover, RIS often extensively involve bilateral carotid arteries, rendering endarterectomy infeasible. Thus, in practice, carotid angioplasty and stenting (CAS) has become an alternative in patients with RIS. 11 In randomized controlled trials that compared CAS with endarterectomy, the risk of ipsilateral ischemic stroke ≤4 years did not differ significantly between the 2 treatments. [12] [13] [14] Periprocedural risk of stroke or death was either similarly low 12, 13 or in some studies, significantly higher with CAS. 14, 15 In patients with severe carotid artery stenosis and increased surgical risk, CAS with emboli-protection device was shown not to be inferior to endarterectomy in the risk of death or ipsilateral stroke at 1 year, and no significant difference could be shown in these outcomes at 3 years. 16 ,17 Yet, recurrent stenosis was more frequent with CAS. 13 However, these results were primarily derived from atherosclerotic stenoses and may not apply to RIS. To date, published CAS studies in RIS involved a relatively small number of patients treated without a uniform procedural protocol; and the results were either inconclusive or contradictory.
Methods

Study Design
Institutional review board approved the study, and we recruited adult patients prospectively from October 2006 to April 2010. Each study participant provided a written informed consent. All patients in the RIS group had definitive radiotherapy for a primary head-and-neck cancer before the stroke onset. Otherwise, the same inclusion criteria (Table 1) were used in recruiting patients into RIS or AS group. We diagnosed carotid stenosis first with ultrasonography, followed by an intra-and extracranial computed tomography or MR angiography for the disease anatomy, lesion extent, and severity. During the study period, 30 patients with RIS underwent medical treatment alone, and no patient with RIS received carotid endarterectomy.
Treatment
All patients received a daily oral dose of 80-mg aspirin and 75-mg clopidogrel for ≥3 days before CAS. Unfractionated heparin was given intravenously to maintain an activated clotting time of 200 to 250 s. We performed CAS by biplane digital subtraction angiography (DSA) equipment under local anesthesia. We used self-expanding closedcell metallic stent (Carotid Wallstent Monorail Endoprosthesis; Boston Scientific Corporation, Natick, MA) and distal cerebral protection device (FilterWire EZ Embolic Protection System, 3.5-5.5 mm; Boston Scientific Corporation). For stenosis >95%, we performed predilation with a 3.5-mm angioplasty balloon (Sterling PTA Balloon Dilatation Catheter; Boston Scientific Corporation) after placement of a distal protection device. To cover the whole length of the stenosis and extend for ≥5 mm on both lesion ends, we used ≥1 stents (in patient with long, extensive lesions) of nominal diameter 5 to 9 mm over internal carotid artery, common carotid artery, or both. The nominal diameter of the stent was selected such that it was not undersized by >1 mm of the largest diameter of the parent artery. To avoid excessive stent coverage, stenoses interrupted by a normal segment within a single vessel were treated with stents separately, leaving a gap in between. We eliminated the spaces created by abrupt plaques between the stent circumference and endoluminal surface by additional stents. We performed postdilation with Sterling PTA Balloon of diameter 4.5 to 8 mm. At the carotid bulb, a balloon of 0.5 to 1 mm greater than the diameter of internal carotid artery was used. For stenosis at common carotid artery, the balloon was sized equal to the diameter of the artery. Balloon inflation was in 5 s and deflation in 10 s. Inflation pressure was ≤12 atmosphere pressures. We treated bilateral carotid stenoses synchronously in the same session if they were both >70% and symptomatic. Patients would receive dual antiplatelet therapy (aspirin 80 mg daily plus clopidogrel 75 mg daily) for 8 weeks after CAS, followed by aspirin alone for life. We concomitantly treated the risk factors for atherosclerosis. Our targets were systolic blood pressure ≤140 mm Hg, glycosylated hemoglobin (HbA1c) ≤6.5%, low-density lipoprotein level ≤130 mg/dL, and abstinence from smoking.
Study End Points
The primary end points were stroke or death within 30 days, and ipsilateral ischemic stroke was >30 days. The secondary end points were angiographic features of RIS, technical success of CAS, procedural characteristics, instent restenosis (ISR), and symptomatic ISR at 2 years. Stroke was any focal nonconvulsive neurological deficit in a vascular territory that persisted for >24 hours. The outcome of stroke was minor if a modified Rankin scale was ≤3 in 3 months. Death was categorized into stroke-related or other causes. Technical success was an uneventful procedure with residual stenosis ≤20% across the whole length of stenosis. ISR was recurrence of stenosis within or at the ends of the stent ≥50% of the parent artery diameter. Symptomatic ISR was ISR associated with ipsilateral stroke or transient ischemic attack (TIA).
Patient Assessment
Certified raters performed National Institutes of Health Stroke Scale before, 1 day after, and on hospital discharge. We recorded modified Rankin scale at 1, 3, and every 6 months thereafter. Patients with suspected new onset stroke or TIA would receive cerebral computed tomography and MRI examination (Wallstent is compatible with 1.5T MRI examination). All patients with RIS would undergo a follow-up DSA at 2 years, whereas patients in AS group would receive an ultrasonography examination first. A follow-up computed tomography or MRI angiography would be arranged if ultrasonography suggested ISR based on the guideline from the Society of Radiologists in Ultrasound. 25 We proceeded to DSA if an ISR was ≥70% and symptomatic. We recorded the stenosis location, severity, and extent and the presence of ulcers, flaps, skipped lesions (ie, separated by a nonstenotic vascular segment), and calcified plaques based on DSA.
Statistical Analysis
We compared the baseline characteristics, angiographic features, treatment parameters, and study end points of the RIS group and AS group by Fisher exact test for categorical data and Mann-Whitney test for continuous data. The cumulative incidence of ipsilateral ischemic stroke beyond 30 days to 6 years was analyzed using Kaplan-Meier method. The differences in incidence and annual risk of ipsilateral ischemic stroke between the 2 groups were estimated using log-rank test.
Results
We recruited 194 patients consecutively for CAS. There were 65 patients in the RIS group and 129 in the AS group. By the end of the 6-year study period (May 2012), the median follow-up time was 39.4 months (95% confidence interval [CI], 20.9-54.5 months) in the RIS group and 45.3 months (23-56.6 months) in the AS group. Imaging assessment for ISR was available in 74 vessels in the RIS group and 120 vessels in the AS group.
Baseline Demographics and Angiographic Features
The median age was 62 years in the RIS group (95% CI, 55-69.5 years) and 73 years in the AS group (67.5-78 years). The male proportion was 81.5% in the RIS group and 78.3% in the AS group. The carotid stenoses were associated with stroke or TIA in 95.4% of RIS group and 97.7% of AS group. Stroke was a more common presenting symptom in the AS group (67.4% versus 36.9%; P<0.01). TIA was more common in the RIS group (58.5% versus 30.2%; P<0.01). Intracranial stenosis (≥70%) was incidentally found in 16 patients of the Table 3 ).
Study End Points
The incidence of stroke or death within 30 days did not differ between RIS group and AS group (1.5% or 1/65 versus 1.6% or 2/129; P=1; Table 4 ). These included 1 minor ipsilateral ischemic stroke in each group and 1 major contralateral hemorrhagic stroke in the AS group. No patient died within 30 days. During the 6-year study period, ipsilateral ischemic stroke occurred in 3 patients in the RIS group on day 39 to 450 (median, 97) and 6 patients in the AS group on day 31 to 1479 (median, 614.5; 4.6% versus 4.7%; P=1). These included 1 major stroke in the RIS group and 3 major stroke in the AS group (Table 4) . Kaplan-Meier analysis showed no significant difference between the 2 groups in cumulative incidence of ipsilateral ischemic stroke beyond 30 days (P=0.50). Their annual risks of ipsilateral ischemic stroke were also 
031).
The types and occurrence of stroke were 1 major ipsilateral hemorrhagic stroke in a patient with RIS on day 1389; 2 contralateral ischemic strokes in the AS group on day 390 and 797, respectively; and 1 minor contralateral hemorrhagic stroke in the RIS group on day 161. During the follow-up period, 14 of 65 patients (21.5%) died in the RIS group, 27 of 129 patients (20.9%) died in the AS group (P=1). Two patients from each group died of stroke. The other causes of death included malignancy, pneumonia, heart failure, and other organ failure.
Discussion
Although both atherosclerosis and radiation may cause carotid stenosis, there is a fundamental difference in pathology between the 2. In animal studies, early radiation-induced arterial injury was characterized by the accumulation of mucopolysaccharide ground substance and alteration and regeneration of elastic tissue, followed by the development of diffused or localized intimal fibrous plaques. 26 Histologically, RIS showed extraordinarily long plaque blended with a thickened intima or welded to all layers of arterial wall and was associated with deep ulcerations. The plaque could be heavily calcified or atypically soft. 27 RIS often involved both the common carotid artery and the internal carotid artery, was more frequently bilateral, and with the maximal stenosis located near the end of the lesion. 28, 29 The distinct pathology in RIS raised the concern whether the clinical and angiographic outcome after ISR would be different between RIS and AS. Through a uniform clinical setting and CAS techniques, our study showed that the pathomorphology of RIS as represented by angiographic features differed from that of AS. RIS were more commonly bilateral, more often located at the common carotid artery, and more associated with occlusion. RIS involved a longer vascular segment and more often associated with skipped lesions and multiple ulcers of characteristic morphology resembling candle-wax. Our study also confirmed that CAS was similarly safe and effective in patients with both RIS and AS in terms of periprocedural complications and prevention of ipsilateral ischemic stroke. The technical demand of CAS in RIS was comparable with that of AS with a similarly high technical success rate. However, RIS was more prone to ISR and symptomatic ISR at 2 years. The overall periprocedural stroke or death rate of 1.5% in our study compared favorably with the 4.4% in a large, multicenter study of 1262 patients treated with cerebral-protected CAS for AS.
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The periprocedural stroke or death rate in previous CAS studies for RIS varied from 1.5% to 8.7% and ISR rate 18% to 47.8%. 18, [20] [21] [22] [23] These results were generally less favorable than those in our study although a direct comparison might not be plausible given the retrospective design, the nonuniform imaging modality/follow-up duration, and the variable use of cerebral protection device and sizing of stent/angioplasty balloon in these studies.
In terms of CAS techniques, there were previously some concerns in RIS: a limitation of balloon inflation to ≤10 atmosphere pressures to avoid arterial rupture 6 ; treating bilateral stenoses in sequential sessions to avoid ischemic complications 6 ; and the abstinence from using cerebral protection device for less procedure-related complications. 18 Nevertheless, in our study, to ensure residual stenosis <20%, we inflated ≤12 atmosphere pressures to overcome heavily fibrotic or calcified lesions. We also oversized balloons by 0.5 to 1 mm in postdilation at carotid bulbs for the same purpose. Moreover, for bilateral stenoses ≥70%, we performed CAS on both sides in the same session to avoid cerebral hypoperfusion over the untreated side that might potentially occur during blood pressure lowering for prevention of hyperperfusion syndrome if only one side of the bilateral lesions was treated. The relatively low periprocedural complication in our study might advocate the safety of these practices. The target of residual stenosis ≤20% through a higher inflation pressure and an oversized balloon might help lower ISR as residual stenosis was known to predict ISR. 30 A closed-cell stent might also reduce ISR by reducing vascular tortuosity, creating a more streamline vascular contour and less turbulent flow. Yet, in tortuous vessels, the use of closed-cell stents demanded a careful selection of landing zone at the distal end to prevent kinking. The relatively higher ISR rate in the RIS group when compared with AS group probably reflected the progressive nature of radiation injury that aggressive cardiovascular risk factor control would not halt.
To date, other treatment options for RIS stroke prevention include carotid endarterectomy and medical therapy. When compared with CAS, carotid endarterectomy might be associated with a less risk of 30-day stroke or TIA (0.028 per person-year versus 0.049 per person-year; P=0.014) and a lower incidence of ISR (0.028 per person-year versus 0.054 per person-year; P<0.003) although carotid endarterectomy was associated with a 9.2% risk of transient or permanent cranial nerve injury. 24 To date, the role of medical treatment in RIS has not been assessed adequately; and the effect of antiplatelet, anticoagulant, antihypertensive, or lipid-lowering therapy in limiting disease progression is still unclear. Our study has several limitations. The single-center nature of this study may limit its generalizability. In addition, for an ethical reason, ultrasonography but not DSA was the first-line screening tool in the AS group. However, ultrasonography might lead to an overestimation of ISR owing to an elevated velocity measurement from an increased stiffness of the vessel by the stent rather than a stenosis. 32 We remedied this limitation by arranging computed tomography/MR angiogram in suspected cases, and definitely, DSA in symptomatic patients with ISR.
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Conclusions
The safety, effectiveness, and technical demand of CAS for RIS is comparable with that for AS although it is associated with a higher rate of ISR.
